Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-blind randomized placebo-controlled study of TAK-442 in acute coronary syndromes
2008-000091-24Phase 2Completed
- Sponsor
- Takeda
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute coronary syndrome (ACS), unstable angina, myocardial infarction (MI) and 1 more comparing TAK-442 plus standard of care with Placebo plus standard of care (2 arms). Primary endpoint: Major bleeding (TIMI). Started Feb 2008; status: completed.
02
Drugs
letaxaban
03
Conditions
acute coronary syndrome (ACS)unstable anginamyocardial infarction (MI)Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2008-000091-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000091-24.